LOTTE BIOLOGICS

Delivering Therapies that
Enable a Healthier World
Inspired by Science

LOTTE BIOLOGICS is dedicated to improving
the lives of patients worldwide as a leading global CDMO.
Embracing Diversity

LOTTE BIOLOGICS embraces diversity
in the pursuit of global well-being.
Fostering Talent

LOTTE BIOLOGICS fosters talent to
lead global healthcare innovations.
Connecting Lives

LOTTE BIOLOGICS connects people to
bridge boundaries and promote sustainability.

About
LOTTE BIOLOGICS

With expertise that spans from development to clinical and commercial production,
LOTTE BIOLOGICS offers end-to-end CDMO services.

Locations

Introducing LOTTE BIOLOGICS' production facilities,
renowned for their top-tier quality and manufacturing capabilities.

Syracuse Bio Campus

(New York, USA)

With a manufacturing capacity of 40,000 liters of
Drug Substance, the Syracuse Bio Campus is also equipped for storage and quality control capabilities.

Songdo Bio Campus

(Incheon, South Korea)

LOTTE BIOLOGICS will begin operations at
our inaugural bio manufacturing facility located at
the Incheon Songdo Bio Campus in 2027, featuring a capacity of 120,000 liters.